Léa Betser, Alicia Le Bras, Harry Etienne, Arnaud Roussel, Antonio Bobbio, Charles Al-Zreibi, Emmanuel Martinod, Marco Alifano, Yves Castier, Jalal Assouad, Isabelle Durand-Zaleski, Pierre Mordant
Robotic-assisted thoracic surgery (RATS) is an effective treatment of non-small cell lung cancer (NSCLC) but the effects of its implementation in university hospital networks has not been described. We analyzed the early clinical outcomes, estimated costs, and revenues associated with three robotic systems implemented in the Paris Public Hospital network. A retrospective study included patients who underwent RATS for NSCLC in 2019 and 2020. Ninety-day morbidity, mortality, hospital costs, and hospital revenues were described...
March 16, 2024: Journal of Robotic Surgery